NCT04741906 Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication
| NCT ID | NCT04741906 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Copenhagen University Hospital at Herlev |
| Condition | Missing Teeth |
| Study Type | OBSERVATIONAL |
| Enrollment | 225 participants |
| Start Date | 2017-08-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 225 participants in total. It began in 2017-08-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Aim of the study is to examine the feasibility of dental implant insertion in patients receiving high, adjuvant and low dose \> 4 years.
Eligibility Criteria
Inclusion Criteria: * Patient with cancer or osteoporosis, treated with antiresorptive treatment. * The patients should have sufficient compliance, this includes willingness to have the planned assessments * The patient should have an expected life span at enrollment of at least 2 years. * The local bone quality and quantity should be sufficient for implant insertion without bone augmentation and is classified according to the classification by Cawood \& Howell 1988. Exclusion Criteria: * \> 10 cigarettes daily * HbA1c \> 53 mmol/mol * Poor oral hygiene * Poor general condition: ECOG score 3 or 4. * Poor prognosis: Expected survival \<2 year is an exclusion cause. * Presence of metastases of the liver brain. * Poor local jaw bone quality acc. to Cawood classification stage 3 or 4. * Unwillingness to comply with the planned assessments and recordings
Contact & Investigator
Sanne Werner Moeller Andersen, DDS
PRINCIPAL INVESTIGATOR
Copenhagen University Hospital, Maxillofacial surgery
Frequently Asked Questions
Who can join the NCT04741906 clinical trial?
This trial is open to participants of all sexes, studying Missing Teeth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04741906 currently recruiting?
Yes, NCT04741906 is actively recruiting participants. Contact the research team at sanne@w-madsen.dk for enrollment information.
Where is the NCT04741906 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT04741906 clinical trial?
NCT04741906 is sponsored by Copenhagen University Hospital at Herlev. The principal investigator is Sanne Werner Moeller Andersen, DDS at Copenhagen University Hospital, Maxillofacial surgery. The trial plans to enroll 225 participants.